This inventor holds 1 USPTO granted patent. Top assignees: Centre Leon Berard, Centre National De La Recherche Scientifique, Institut National De La Sante Et De La Recherche Medicale. Active years: 2026.
Company Filing History:
1 out of 39 
1 out of 123 
1 out of 12 Years Active: 2026
Title: Flora Clément: Innovator in Cancer Prognosis
Introduction
Flora Clément is a notable inventor based in Grenoble, France. She has made significant contributions to the field of cancer research, particularly in the area of prognosis methods. Her innovative approach has the potential to improve patient outcomes and treatment strategies.
Latest Patents
Flora Clément holds a patent for a prognosis method of cancer. This method involves determining the amount of the product of each of at least 21 genes from a group of 160 genes, as set forth in SEQ ID NO: 1 to SEQ ID NO: 160. This groundbreaking technique aims to assess patient outcomes and resistance to chemotherapy treatments for individuals afflicted by tumors.
Career Highlights
Throughout her career, Flora has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the Centre Léon Bérard. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Flora has collaborated with notable colleagues, including Véronique Maguer-Satta and Boris Guyot. These partnerships have enriched her research and expanded the impact of her work in cancer prognosis.
Conclusion
Flora Clément's innovative contributions to cancer prognosis highlight her dedication to improving patient care through scientific research. Her work continues to inspire advancements in the medical field.